Serving To Educate Primary Care Clinicians On Respiratory Issues
Evidence Based Medicine Header 1
Medical Education Header 2
Metabolic Diseases Header 4
News: Articles from our Partners at Consultant 360 February 2021

New Respiratory Disease Articles from our Partners at Consultant 360

The Impact of Well-Child Visits on Asthma Management

In this month’s Pediatric Top Paper, Jessica Tomaszewski, MD, writes about a study that evaluated the effect of a wellness visit on the risk of asthma exacerbations among children and adolescents.

Steps to Understanding the Natural History of COPD

In this video, Antonio Anzueto, MD, talks about the next steps in his research into treatment options for patients with symptomatic COPD who are at high risk of exacerbations.

Overview: Single-Inhaler Triple Therapy Compared With Monotherapy In COPD

In this video, Antonio Anzueto, MD, gives an overview of his team's study that compared fluticasone furoate/umeclidinium/vilanterol in a single inhaler with tiotropium among patients with symptomaticCOPD, who are at risk of exacerbations.

How Are Asthma Outcomes Affected By Early Antibiotic Treatment? 

In a recent study, researchers investigated the effectiveness of antibiotic use in children hospitalized with asthma exacerbation who had no indications of bacterial infection. 

Fluticasone Furoate/Umeclidinium/Vilanterol Compared With Tiotropium for COPD

In this video, Antonio Anzueto, MD, talks about the main take-away messages from his team's study that compared fluticasone furoate/umeclidinium/vilanterol in a single inhaler with tiotropium among patients with symptomatic COPD, who are at risk of exacerbations.